A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Completed
Merck Sharp & Dohme Corp.
Phase 2
2006-12-01
The purpose of this trial is to determine the safety, efficacy and tolerability of two doses
of the study drug compared to placebo for the treatment of subjects with seasonal allergic
rhinitis.
Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2007-12-18
The purpose of this study is to determine the safety and efficacy of epinastine nasal spray
compared to placebo for the treatment of subjects with seasonal allergic rhinitis
Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis
Completed
Merck Sharp & Dohme Corp.
Phase 2
2006-09-01
The objectives of this study were to:
- Examine the tolerability of two formulations and two dose concentrations of epinastine.
- Select formulation(s) of epinastine for future studies by evaluating the individual
sensory attribute scores of the Nasal Spray Evaluation Questionnaire (NSEQ) collected
after each study drug administration and the subject preference ranking assessed at the
completion of the study.
- Compare the preference of two formulations and two dose concentrations of epinastine
compared to azelastine following a single dose of each in a randomized, double-blind,
two-cohort, three-period crossover design.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
